ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

MORF Morphic Holding Inc

29,90
1,19 (4,14%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Morphic Holding Inc MORF NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
1,19 4,14% 29,90 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
29,85 29,075 30,30 29,90 28,71
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.4.202413:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
19.3.202413:00GLOBEMorphic Appoints Dr. Simon Cooper as Chief Medical Officer
05.3.202422:05GLOBEMorphic to Participate in March Investor Conferences
22.2.202413:46EDGAR2Form S-8 - Securities to be offered to employees in employee..
22.2.202413:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.2.202413:04EDGAR2Form 8-K - Current report
22.2.202413:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
18.1.202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:08EDGAR2Form 8-K - Current report
03.1.202422:05GLOBEMorphic to Present at the 42nd Annual J.P. Morgan Healthcare..
06.12.202314:57EDGAR2Form 8-K - Current report
10.11.202314:00GLOBEMorphic to Present at November Investor Conferences
03.11.202312:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202312:13EDGAR2Form 8-K - Current report
03.11.202312:00GLOBEMorphic Announces Corporate Highlights and Financial Results..
12.10.202314:52EDGAR2Form 8-K - Current report
09.10.202314:00GLOBEMorphic Therapeutic to Host Webcast to Present EMERALD-1..
26.9.202323:30EDGAR2Form 8-K - Current report
26.9.202322:10GLOBEMorphic Holdings Announces CEO Dr. Praveen Tipirneni to Take..
22.9.202323:30GLOBEMorphic to Present Positive EMERALD-1 Phase 2a Data for..
09.9.202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.9.202322:24EDGAR2Form 144 - Report of proposed sale of securities
29.8.202314:00GLOBEMorphic Announces Participation in 2023 Wells Fargo..
09.8.202322:05GLOBEMorphic to Present at the Canaccord Genuity 43rd Annual..
04.8.202300:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.8.202313:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202313:08EDGAR2Form 8-K - Current report
03.8.202313:05GLOBEMorphic Announces Corporate Highlights and Financial Results..
07.7.202301:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.6.202322:05GLOBEMorphic to Present at the Jefferies Global Healthcare..
12.5.202314:30GLOBEMorphic to Present at 2023 RBC Capital Markets Global..
11.5.202314:00GLOBEMorphic Presents New Biomarker Data at DDW 2023 Supporting..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock